954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus

• Richard Casey,
• Wenliang Dong,
• Tereza Brachtlova,
• Allan Abramovitch,
• Jonathan Giddens,
• Peter Incze,
• Kenneth Jansz,
• Victor van Beusechem

Affiliations

Richard Casey

4The Fe/Male Health Centres, Oakville, Canada

Wenliang Dong

Department of Pharmacy, Peking University People`s Hospital, Beijing, China

Tereza Brachtlova

1ORCA Therapeutics BV, Den Bosch, Netherlands

Allan Abramovitch

2Urology and Male Infertility Clinic, Scarboropugh, Canada

Jonathan Giddens

3Jonathan Giddens Medicine Professional Corp, Brampton, Canada

Peter Incze

4The Fe/Male Health Centres, Oakville, Canada

Kenneth Jansz

5G. Kenneth Jansz Medicine Professional Corp, Burlington, Canada

Victor van Beusechem

6Amsterdam University Medical Center, Amsterdam, Netherlands